The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution

Cell Transplantation

Volumn 17, Issue 8, 2008, Pages 923-941

  Schäfer, Richard ^a   Ayturan, Miriam ^b   Bantleon, Rüdiger ^a   Kehlbach, Rainer ^a   Siegel, Georg ^a   Pintaske, Joerg ^a   Conrad, Sabine ^c   Wolburg, Hartwig ^c   Northoff, Hinnak ^a   Wiskirchen, Jakub ^a   Weissert, Robert ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Experimental autoimmune encephalomyelitis; Homing; Imaging; Mesenchymal stem cells; Multiple sclerosis; Small particles of iron oxide

Indexed keywords

FERUCARBOTRAN; IRON OXIDE; NANOPARTICLE; SMALL PARTICLE OF IRON OXIDE; UNCLASSIFIED DRUG; COLORING AGENT; FERRIC ION; FERRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL LABELING; CELL TRANSFER; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; IRON METABOLISM; LIVER; MESENCHYMAL STEM CELL; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TISSUE DISTRIBUTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GRAFT SURVIVAL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STAINING; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; COLORING AGENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FERRIC COMPOUNDS; GRAFT SURVIVAL; LIVER; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIPLE SCLEROSIS; RATS; STAINING AND LABELING;

EID: 58149373636     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786576480     Document Type: Article

References (60)

1. Arbab, A. S.; Yocum, G. T.; Wilson, L. B.; Parwana, A.; Jordan, E. K.; Kalish, H.; Frank, J. A. Comparison of transfection agents in forming complexes with ferumox-ides, cell labeling efficiency, and cellular viability. Mol. Imaging 3:24-32; 2004.
2. Brochet, B.; Deloire, M. S.; Touil, T.; Anne, O.; Caille, J. M.; Dousset, V.; Petry, K. G. Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. Neuroimage 32:266-274; 2006.
3. Brundin, L.; Brismar, H.; Danilov, A. I.; Olsson, T.; Johansson, C. B. Neural stem cells: A potential source for remyelination in neuroinflammatory disease. Brain Pathol. 13:322-328; 2003.
4. Bulte, J. W.; Douglas, T.; Witwer, B.; Zhang, S. C.; Strable, E.; Lewis, B. K.; Zywicke, H.; Miller, B.; van Gelderen, P.; Moskowitz, B. M.; Duncan, I. D.; Frank, J. A. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19:1141-1147; 2001.
5. Colter, D. C.; Sekiya, I.; Prockop, D. J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 98:7841-7845; 2001.
6. Deshpande, D. M.; Kim, Y. S.; Martinez, T.; Carmen, J.; Dike, S.; Shats, I.; Rubin, L. L.; Drummond, J.; Krishnan, C.; Hoke, A.; Maragakis, N.; Shefner, J.; Rothstein, J. D.; Kerr, D. A. Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol. 60:32-44; 2006.
7. De Stefano, N.; Bartolozzi, M. L.; Guidi, L.; Stromillo, M. L.; Federico, A. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. J. Neurol. Sci. 233:203-208; 2005.
8. Dick, A. J.; Guttman, M. A.; Raman, V. K.; Peters, D. C.; Pessanha, B. S.; Hill, J. M.; Smith, S.; Scott, G.; McVeigh, E. R.; Lederman, R. J. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 108:2899-2904; 2003.
9. Dousset, V.; Brochet, B.; Deloire, M. S.; Lagoarde, L.; Barroso, B.; Caille, J. M.; Petry, K. G. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. Am. J. Neuroradiol. 27:1000-1005; 2006.
10. Einstein, O.; Fainstein, N.; Vaknin, I.; Mizrachi-Kol, R.; Reihartz, E.; Grigoriadis, N.; Lavon, I.; Baniyash, M.; Lassmann, H.; Ben-Hur, T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 61:209-218; 2007.
11. Flacke, S.; Fischer, S.; Scott, M. J.; Fuhrhop, R. J.; Allen, J. S.; McLean, M.; Winter, P.; Sicard, G. A.; Gaffney, P. J.; Wickline, S. A.; Lanza, G. M. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 104:1280-1285; 2001.
12. Gerdoni, E.; Gallo, B.; Casazza, S.; Musio, S.; Bonanni, I.; Pedemonte, E.; Mantegazza, R.; Frassoni, F.; Mancardi, G.; Pedotti, R.; Uccelli, A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61: 219-227; 2007.
13. Grant, S. M.; Wiesinger, J. A.; Beard, J. L.; Cantorna, M. T. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J. Nutr. 133:2635-2638; 2003.
14. Herrmann, M. M.; Gaertner, S.; Stadelmann, C.; van den Brandt, J.; Boscke, R.; Budach, W.; Reichardt, H. M.; Weissert, R. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 106:1875-1883; 2005.
15. Huber, M. M.; Staubli, A. B.; Kustedjo, K.; Gray, M. H.; Shih, J.; Fraser, S. E.; Jacobs, R. E.; Meade, T. J. Fluores-cently detectable magnetic resonance imaging agents. Bioconjug. Chem. 9:242-249; 1998.
16. Inoue, S.; Popp, F. C.; Koehl, G. E.; Piso, P.; Schlitt, H. J.; Geissler, E. K.; Dahlke, M. H. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81:1589-1595; 2006.
17. Javazon, E. H.; Colter, D. C.; Schwarz, E. J.; Prockop, D. J. Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 19:219-225; 2001.
18. Jendelova, P.; Herynek, V.; DeCroos, J.; Glogarova, K.; Andersson, B.; Hajek, M.; Sykova, E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 50:767-776; 2003.
19. Jendelova, P.; Herynek, V.; Urdzikova, L.; Glogarova, K.; Kroupova, J.; Andersson, B.; Bryja, V.; Burian, M.; Hajek, M.; Sykova, E. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76:232-243; 2004.
20. Ji, J. F.; He, B. P.; Dheen, S. T.; Tay, S. S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22: 415-427; 2004.
21. Kalish, H.; Arbab, A. S.; Miller, B. R.; Lewis, B. K.; Zywicke, H. A.; Bulte, J. W.; Biyant, L. H.; Frank, J. A. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 50:275-282; 2003.
22. Kern, S.; Eichler, H.; Stoeve, J.; Klüter, H.; Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 24:1294-1301; 2006.
23. Keyser, K. A.; Beagles, K. E.; Kiem, H. P. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 16:555-562; 2007.
24. Kim, D.; Chun, B. G.; Kim, Y. K.; Lee, Y. H.; Park,C. S.; Jeon, I.; Cheong, C.; Hwang, T. S.; Chung, H.; Gwag, B. J.; Hong, K. S. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant. 16:1007-1012; 2007.
25. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
26. Levine, S.; Sowinski, R. Carbonyl iron: A new adjuvant for experimental autoimmune diseases. J. Immunol. 105: 1530-1535; 1970.
27. Levine, S. M.; Chakrabarty, A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1012:252-266; 2004.
28. Li, H.; Guo, Z. K.; Li, X. S.; Hou, C. M.; Tang, P. H.; Mao, N. Functional and phenotypic alteration of intra-splenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model. Cell Transplant. 16:85-95; 2007.
29. Lindvall, O.; Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 441:1094-1096; 2006.
30. Linker, R. A.; Kroner, A.; Horn, T.; Gold, R.; Maurer, M.; Bendszus, M. Iron particle-enhanced visualization of inflammatory central nervous system lesions by high resolution: Preliminary data in an animal model. Am. J. Neuroradiol. 27:1225-1229; 2006.
31. Luker, G. D.; Piwnica-Worms, D. Molecular imaging in vivo with PET and SPECT. Acad. Radiol. 8:4-14; 2001.
32. Lutz, A. M.; Willmann, J. K.; Goepfert, K.; Marincek, B.; Weishaupt, D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced Tl-weighted MR imaging. Radiology 237:520-528; 2005.
33. Mahmood, U.; Weissleder, R. Near-infrared optical imaging of proteases in cancer. Mol. Cancer Ther. 2:489-496; 2003.
34. Martino, G.; Pluchino, S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 7:395-406; 2006.
35. Metz, S.; Bonaterra, G.; Rudelius, M.; Settles, M.; Rummeny, E. J.; Daldrup-Link, H. E. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14:1851-1858; 2004.
36. Modo, M.; Cash, D.; Mellodew, K.; Williams, S. C.; Fraser, S. E.; Meade, T. J.; Price, J.; Hodges, H. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 17:803-811; 2002.
37. Noseworthy, J. H.; Lucchinetti, C.; Rodriguez, M.; Weinshenker, B. G. Multiple sclerosis. N. Engl. J. Med. 343: 938-952; 2000.
38. Pawelczyk, E.; Arbab, A. S.; Pandit, S.; Hu, E.; Frank, J. A. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: Implications for cellular magnetic resonance imaging. NMR Biomed. 19:581-592; 2006.
39. Pedchenko, T. V.; Levine, S. M. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice, J. Neuroimmunol. 84:188-197; 1998.
40. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage po-tential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
41. Pluchino, S.; Quattrini, A.; Brambilla, E.; Gritti, A.; Salani, G.; Dina, G.; Galli, R.; Del Carro, U.; Amadio, S.; Bergami, A.; Furlan, R.; Vescovi, A. L.; Martino, G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422:688-694; 2003.
42. Pluchino, S.; Zanotti, L.; Rossi, B.; Brambilla, E.; Ottoboni, L.; Salani, G.; Martinello, M.; Cattalini, A.; Bergami, A.; Furlan, R.; Comi, G.; Constantin, G. Neurospherederived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436:266-271; 2005.
43. Raynal, I.; Prigent, P.; Peyramaure, S.; Najid, A.; Rebuzzi, C.; Corot, C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39:56-63; 2004.
44. Reimer, P.; Weissleder, R.; Lee, A. S.; Wittenberg, J.; Brady, T. J. Receptor imaging: application to MR imaging of liver cancer. Radiology 177:729-734; 1990.
45. Ringden, O.; Uzunel, M.; Rasmusson, I.; Remberger, M.; Sundberg, B.; Lonnies, H.; Marschall, H. U.; Dlugosz, A.; Szakos, A.; Hassan, Z.; Omazic, B.; Aschan, J.; Barkholt, L.; Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397; 2006.
46. Riister, B.; Gottig, S.; Ludwig, R. J.; Bistrian, R.; Müller, S.; Seifried, E.; Gille, J.; Henschler, R. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108:3938-3944; 2006.
47. Schäfer, R.; Kehlbach, R.; Wiskirchen, J.; Bantleon, R.; Pintaske, J.; Brehm, B. R.; Gerber, A.; Wolburg, H.; Claussen, C. D.; Northoff, H. Transferrin receptor upregu-lation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 244:514-523; 2007.
48. Schoepf, U.; Marecos, E. M.; Melder, R. J.; Jain, R. K.; Weissleder, R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 24: 642-651; 1998.
49. Storch, M. K.; Stefferl, A.; Brehm, U.; Weissert, R.; Wall-strom, E.; Kerschensteiner, M.; Olsson, T.; Linington, C.; Lassmann, H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681-694; 1998.
50. Sun, J. H.; Teng, G. J.; Ju, S. H.; Ma, Z. L.; Mai, X. L.; Ma, M. MR tracking of magnetically labeled mesenchy-mal stem cells in rat kidneys with acute renal failure. Cell Transplant. 17:279-290; 2008.
51. Sykova, E.; Jendelova, P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 4:1336-1342; 2007.
52. Uccelli, A.; Zappia, E.; Benvenuto, F.; Frassoni, F.; Mancardi, G. Stem cells in inflammatory demyelinating disorders: A dual role for immunosuppression and neuroprotection. Expert Opin. Biol. Ther. 6:17-22; 2006.
53. Unger, E. C. How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology 229: 615-616; 2003.
54. Urdzikova, L.; Jendelova, P.; Glogarova, K.; Burian, M.; Hajek, M.; Sykova, E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J. Neurotrauma 23:1379-1391; 2006.
55. Vogl, T. J.; Hammerstingl, R.; Schwarz, W.; Kummel, S.; Müller, P. K.; Balzer, T.; Lauten, M. J.; Balzer, J. O.; Mack, M. G.; Schimpfky, C.; Schrem, H.; Bechstein, W. O.; Neuhaus, P.; Felix, R. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest. Radiol. 31:696-708; 1996.
56. Wang, Y. X.; Hussain, S. M.; Krestin, G. P. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11:2319-2331; 2001.
57. Weissert, R.; Wallstrom, E.; Storch, M. K.; Stefferl, A.; Lorentzen, J.; Lassmann, H; Linington, C.; Olsson, T. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1265-1273; 1998.
58. Wersebe, A.; Wiskirchen, J.; Decker, U.; Schick, F.; Dietz, K.; Müller-Schimpfle, M.; Claussen, C. D.; Pereira, P. L. Comparison of gadolinium-BOPTA and ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient. Invest. Radiol. 41:264-271; 2006.
59. Yeh, T. C.; Zhang, W.; Ildstad, S. T.; Ho, C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn. Reson. Med. 33: 200-208; 1995.
60. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761; 2005.